The efficacy and safety of mirabegron compared with solifenacin in overactive bladder patients dissatisfied with previous antimuscarinic treatment due to lack of efficacy: Results of a noninferiority, randomized, phase IIIb trial

  1. Batista, J.E.
  2. Kölbl, H.
  3. Herschorn, S.
  4. Rechberger, T.
  5. Cambronero, J.
  6. Halaska, M.
  7. Coppell, A.
  8. Kaper, M.
  9. Huang, M.
  10. Siddiqui, E.
Revista:
Therapeutic Advances in Urology

ISSN: 1756-2880,  1756-2872

Any de publicació: 2015

Volum: 7

Número: 4

Pàgines: 167-179

Tipus: Article

DOI: 10.1177/1756287215589250 GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus